Revance Therapeutics, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Newark CA United States (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2008
NCT00888914
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Revance Therapeutics, Inc.